Are your patent claims a mousetrap with no cheese?
Life Techs. Corp. v. Promega Corp., 137 S. Ct. 734 (2017) Licensing multi-component inventions sourced only in part in the U.S. creates ample risk that a licensee can avoid paying any patent royalty outside the U.S. The Life Techs. decision explains ...